{"url_path":"/sec/tpst/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-224156-index.html","accession_number":"0001193125-26-224156","cik":"0001544227","ticker":"TPST","issuer_name":"Tempest Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-224156-index.html","primary_entity_key":"0001544227","primary_entity_name":"Tempest Therapeutics, Inc."},"word_count":79,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press release dated May 14, 2026](tpst-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nTEMPEST THERAPEUTICS, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 14, 2026\n\nBy:\n\n/s/ Matthew Angel\n\n \n\n \n\nName:\n\nMatthew Angel\n\n \n\n \n\nTitle:\n\nChief Executive Officer"}